drug
alcaftadine
Marketedupdated 3mo agoby Fosun Pharma USA Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 19, 2027
214 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Dec 23, 2027method-of-use (U-3267)US 86642151.4y
- Mar 19, 2027formulationUS 10617695214d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that